Rigvir Virotherapy

Hope4Cancer® Institute introduces Rigvir® Cancer Virotherapy as a brand new therapy.  

  • Rigvir® is a registered anticancer drug from the Latvian Virotherapy Center (www.virotherapy.eu).
  • Rigvir® is supported by a legacy of over 50 years of research that includes numerous clinical trials on thousands of patients.
  • Rigvir® has a demonstrated selective efficacy against a variety of tumors as well as powerful immune system modulating properties that make the cancer vulnerable to further attack. 
  • Rigvir® has an exceptional safety profile - non-pathogenic (does not replicate or cause disease in humans), phenomenal therapeutic index, unrivaled by standard chemotherapy and radiotherapy treatments.

Hope4Cancer® Institute is proud to announce its accreditation by the Latvian Virotherapy Center as a clinic authorized to treat patients with Rigvir® in Mexico.  Download the free Rigvir E-book!


Virotherapy is emerging as a new wave in oncological treatments.  Rigvir® is the world's first cancer virotherapy agent, the only one that is not genetically modified. Rigvir® has oncotropic and oncolytic ("seek" and "destroy") properties selectively against cancer cells.  Once assimilated by the cancer cell, Rigvir® replicates in the cell which dies in the process.  Healthy cells are not affected, resulting in no side effects and a high quality of life.




Rigvir® is an intensely studied live virus that has been shown to be non-replicative, i.e. it does not reproduce inside the human body nor does it transmit to others. While many pharmaceutical companies are working on the development of virotherapies, none of their engineered clinical candidates can boast of an effectiveness and safety profile anywhere close to that historically established for Rigvir®.

Rigvir® has passed all phases of clinical trials and is registered in Latvia as a prescription drug for the treatment of cancerRigvir® is an approved, state-sponsored medicine used by oncologists and sold in pharmacies in Latvia, and is also available through representatives in a few other countries. As a consequence of our accreditation by the Latvian Virotherapy Center, Rigvir® is now available as a standalone Hope4Cancer® treatment protocol.


Does Rigvir® Cancer Virotherapy Work Against All Cancers?

Initially developed as a powerful drug against melanoma, Rigvir is now approved as a medicine against numerous other cancers including the folllowing:

  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Many types of Sarcoma

Rigvir® may also work against other cancers, but any other cancer types not on the list must be first evaluated by the medical team.


During his recent trip to Latvia, Dr. Antonio Jimenez, Medical Director of Hope4Cancer® Institute, completed an extensive training course on the use of virotherapy with Rigvir® in oncology and for the prevention of secondary immune deficiency.  He also signed a Memorandum of Cooperation with the President and CEO of that Latvian Medical Export Association, Mr. Andrei Repisevski and the Managing Director of the Latvian Virotherapy Center, Ms. Gunta Kalnina, paving the way towards establishing cooperative efforts with Hope4Cancer® Institute to develop Rigvir® as a cancer treatment in different countries across the world.



Rigvir® is labelled as a "medicine" or "drug", does it classify as chemotherapy? 

The answer is no.  Hope4Cancer® Institute is cautious to introduce pharmaceutical products that could prove to be non-selective and toxic to its patients.  While Rigvir® is a registered cancer medicine (drug) in Latvia, its ability to target cancer cells specifically and induce an immune response (also known as viral immunotherapy), completely safe clinical profile, high therapeutic index, and absence of side effects makes it unlike all available chemotherapy agents today.


On the same token, Rigvir® does not fall into the category of alternative and complementary medicine either, since it is a specific, defined pharmaceutical entity that has been established through a process of validated studies to qualify as a cancer drug.  In other words, Rigvir® represents a totally new paradigm in cancer treatment, a new form of biologically targeted therapy, and adds to our portfolio of evidence-based cancer treatments.



"Interested in Rigvir®, who should I contact?" 

Rigvir® therapy may not be for everybody.  Find out if your condition qualifies for Rigvir® Cancer Virotherapy by contacting a Hope4Cancer® Institute Patient Coordinator through this website, and we will be happy to arrange for a free consultation between you and our Medical Director, Dr. Antonio Jimenez, to determine your eligibility for Rigvir® or other treatment options.


 

New patient form

new patient form

Disclaimers*

This website does not make any health claims or promise to treat any or all illnesses.  We cannot promise or guarantee results in anyway. Individual results may vary. The information introduced does not take the place of physician's care, medical procedures, lab tests or any necessary medication. Written and video testimonials on this site are real life individual experiences of those who have used our treatments, products and services.   Results vary, and we do not claim that their results are typical.  The testimonials are not necessarily representative of all of those who will use our treatments, products and/or services.  The testimonials are not intended to make claims that our treatments, products and/or services can be used to diagnose, treat, cure or prevent any disease.  These claims have not been clinically proven or evaluated by the FDA.

Contact us

Our patient coordinator will be happy to answer your questions and discuss your treatment options!

Call us: 1-888-544-5993
International Patients
(outside the U.S.A.),
Please Call:  (619) 669-6511

Fax: (619) 956-7071

WEBSITE TERMS OF USE AND CONDITIONS

Read Our Privacy Policy
Hope4Cancer Operational Permits and Site-Wide Disclaimers

RocketTheme Joomla Templates